Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1014

1.

Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.

Cacoub P, Rosenthal E, Gerolami V, Hausfater P, Ghillani P, Sterkers Y, Thibault V, Khiri H, Piette JC, Halfon P.

Clin Microbiol Infect. 2003 Jan;9(1):39-44.

2.

Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.

Zignego AL, Ferri C, Giannini C, La Civita L, Careccia G, Longombardo G, Bellesi G, Caracciolo F, Thiers V, Gentilini P.

Arch Virol. 1997;142(3):545-55.

PMID:
9349300
3.

Mixed cryoglobulinemia and hepatitis C virus.

Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, Huraux JM, Piette JC, Godeau P.

Am J Med. 1994 Feb;96(2):124-32.

PMID:
7509124
4.

Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.

Cacoub P, Bourlière M, Hausfater P, Charlotte F, Khiri H, Toci S, Piette JC, Poynard T, Halfon P.

J Viral Hepat. 2003 Jan;10(1):10-5.

PMID:
12558906
5.

Hepatitis C virus risk: a hepatitis C virus related syndrome.

Mazzaro C, Panarello G, Tesio F, Santini G, Crovatto M, Mazzi G, Zorat F, Tulissi P, Pussini E, Baracetti S, Campanacci L, Pozzato G.

J Intern Med. 2000 May;247(5):535-45.

6.

TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses.

Masia G, Ingianni A, Demelia L, Faa G, Manconi PE, Pilleri G, Ciancio A, Rizzetto M, Coppola RC.

J Viral Hepat. 2001 Sep;8(5):384-90.

PMID:
11555197
7.

Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon.

Nishizawa Y, Tanaka E, Orii K, Rokuhara A, Ichijo T, Yoshizawa K, Kiyosawa K.

J Gastroenterol Hepatol. 2000 Nov;15(11):1292-7.

PMID:
11129224
8.

Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.

Terrier B, Sène D, Saadoun D, Ghillani-Dalbin P, Thibault V, Delluc A, Piette JC, Cacoub P.

Ann Rheum Dis. 2009 Jan;68(1):89-93. doi: 10.1136/ard.2007.086488.

PMID:
18375535
9.

Anti-endothelial cell auto-antibodies in hepatitis C virus mixed cryoglobulinemia.

Cacoub P, Ghillani P, Revelen R, Thibault V, Calvez V, Charlotte F, Musset L, Youinou P, Piette JC.

J Hepatol. 1999 Oct;31(4):598-603.

PMID:
10551381
10.

High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.

Realdon S, Pontisso P, Adami F, Trentin L, Noventa F, Ferrari A, Migliorato I, Gatta A, Alberti A.

J Hepatol. 2001 May;34(5):723-9.

PMID:
11434619
11.

Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection.

Hu YW, Al-Moslih MI, Al Ali MT, Uzicanin S, Perkins H, Yi QL, Rahimi Khameneh S, Wu J, Brown EG.

J Med Virol. 2008 Feb;80(2):365-71.

PMID:
18098140
12.

Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.

Bianco E, Marcucci F, Mele A, Musto P, Cotichini R, Sanpaolo MG, Iannitto E, De Renzo A, Martino B, Specchia G, Montanaro M, Barbui AM, Nieddu R, Pagano L, Rapicetta M, Franceschi S, Mandelli F, Pulsoni A; Italian Multi-Center case-control study..

Haematologica. 2004 Jan;89(1):70-6.

13.

Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas.

Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, Marrocchi ME, Di Pietro E, La Villa G, Laffi G, Gentilini P.

Ann Intern Med. 2002 Oct 1;137(7):571-80.

PMID:
12353944
14.

Hepatitis C virus but not GB virus C/hepatitis G virus has a role in type II cryoglobulinemia.

Liu F, Knight GB, Agnello V.

Arthritis Rheum. 1999 Sep;42(9):1898-901.

15.

High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.

Nakagawa N, Ikoma J, Ishihara T, Yasui N, Fujita N, Iwasa M, Kaito M, Watanabe S, Adachi Y.

Cancer. 1999 Oct 15;86(8):1437-40.

PMID:
10526270
16.

Effect of TT virus co-infection on interferon response in chronic hepatitis C patients.

Kawanaka M, Niiyama G, Mahmood S, Ifukube S, Yoshida N, Onishi H, Hanano S, Ito T, Yamada G.

Liver. 2002 Aug;22(4):351-5.

PMID:
12296969
17.

Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India.

Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P.

Hemodial Int. 2005 Oct;9(4):362-6.

PMID:
16219056
18.

Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases.

Tuveri R, Jaffredo F, Lunel F, Nalpa B, Pol S, Feray C, Marcellin P, Thibault V, Delagneau JF, Opolon P, Scarpa B, Bréchot C, Thiers V.

J Hepatol. 2000 Jul;33(1):121-7.

PMID:
10905595
19.

Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia.

Fabris M, Quartuccio L, Salvin S, Pozzato G, De Re V, Mazzaro C, Ferri C, Baldini C, De Vita S.

Ann Rheum Dis. 2008 Jan;67(1):80-3.

PMID:
17526550
20.

Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.

Mizorogi F, Hiramoto J, Nozato A, Takekuma Y, Nagayama K, Tanaka T, Takagi K.

Intern Med. 2000 Feb;39(2):112-7. Review.

Supplemental Content

Support Center